BNP Paribas Financial Markets
HITK

BNP Paribas Financial Markets’s HI-TECH PHARMACAL INC HITK Stock Holding History

BNP Paribas Financial Markets’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-163
Closed -$7.07K – 4199
2013
Q4 		$7.07K Buy
+163
New +$7.04K ﹤0.01% 2872

Other funds holding HITK

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's HITK Position: Q1 2014 in Review

BNP Paribas Financial Markets sold out of HI-TECH PHARMACAL INC (HITK) in Q1 2014, closing a stake of 163 shares — an estimated $7.07K sold.

BNP Paribas Financial Markets first reported a position in HITK in Q4 2013 and held it in 1 quarter. The position peaked at $7.07K in Q4 2013. 108 funds tracked by Wall St. Rank hold HITK as of Q1 2014.

  • BNP Paribas Financial Markets reported no remaining HI-TECH PHARMACAL INC position as of Q1 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 163 HI-TECH PHARMACAL INC shares in Q1 2014, an estimated $7.07K.
  • BNP Paribas Financial Markets first reported a position in HI-TECH PHARMACAL INC in Q4 2013 and held it in 1 quarter.
  • BNP Paribas Financial Markets's HI-TECH PHARMACAL INC position peaked at $7.07K in Q4 2013.
  • 108 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q1 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.